PepsiCo CEO sees “big opportunities” from GLP-1 drugs
The use of the medication is on the rise and data appears to show a reduced appetite for snacks.
04 February 2026
04 February 2026
The use of the medication is on the rise and data appears to show a reduced appetite for snacks.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.